Ferumoxytol
Download the GastroMARK® Package Insert
GastroMARK®
GastroMARK® (generic name: ferumoxsil) is AMAG Pharmaceuticals' oral gastrointestinal imaging agent used to distinguish the loops of the bowel from other abdominal structures and physiology. Images of organs and tissues in
the abdomen using MRI without contrast agents can be difficult
the abdomen using MRI without contrast agents can be difficult
to read because the abdominal organs and tissues cannot be easily distinguished from the loops of the bowel GastroMARK® flows through and darkens the bowel when ingested. By more clearly identifying the intestinal loops, GastroMARK® enhances ability to distinguish the bowel from adjacent tissues and organs in the upper gastrointestinal tract.
GastroMARK® is marketed in the United States by Covidien, Ltd. For more information regarding GastroMARK® please contact Covidien, Ltd.. at (888) 744–1414. GastroMARK® is marketed in western Europe and Brazil by Guerbet S.A. under the tradename Lumire™. Additionally, in Europe GastroMARK® is approved for rectal administration to delineate the lower intestinal system.
